期刊文献+

1例预防性使用地塞米松后出现奥沙利铂急性过敏反应的文献复习 被引量:1

One case of acute anaphylaxis induced by oxaliplatin with prophylactic use of dexamethasone: case report and literature review
原文传递
导出
摘要 目的:回顾性分析预防性使用糖皮质激素仍然出现奥沙利铂过敏反应的可能原因及预防措施。方法:回顾性分析奥沙利铂急性过敏反应的可能机制、相关因素及不良反应的预防措施。结果:奥沙利铂急性过敏反应可能是Ig E介导的Ⅰ型过敏反应,年轻、女性、既往应用过奥沙利铂、累积剂量达600 mg·m-2以上、低剂量地塞米松预处理等均是奥沙利铂过敏反应的高危因素,高剂量的地塞米松可降低奥沙利铂再次发生过敏反应的发生率及严重程度。结论:有高危因素的患者在应用奥沙利铂时,应预防性给予高剂量地塞米松和5-HT3受体阻断剂,为避免再次过敏,可使用奥沙利铂脱敏治疗。 Objective: This study was designed to explore the reason and prevention measures of acute anaphylaxis of oxaliplatin with use of dexamethasone in advance. Methods: The pathogenesis, related factors and prevention measures of side effects were analyzed retrospectively. Results: Acute anaphylaxis induced by oxaliplatin may be mediated by Ig E mediated type Ⅰ anaphylaxis, younger, female, already received oxaliplatin, oxaliplatin cumulative dose 600 mg·m^-2 and prophylactic use of low-dose dexamethasone were high risk factors of acute anaphylaxis induced by oxaliplatin. However, the incidence and degree of acute anaphylaxis induced by retreated with oxaliplatin were declined by high-dose dexamethasone. Conclusion: High-dose dexamethasone and 5-hydroxytryptamine-3 antagonist should be used in patients with high risk factors in advance, and acute anaphylaxis could be avoided by oxaliplatin desensitization therapy.
作者 司倩 陈楠 葛春丽 SI Qian;CHEN Nan;GE Chun-li(Department of Clinical Pharmacy, AffiliatedZhengzhou People's Hospital, Southern Medical University, Zhengzhou 450000, Chin)
出处 《临床药物治疗杂志》 2018年第5期90-92,共3页 Clinical Medication Journal
关键词 奥沙利铂 地塞米松 机制 高危因素 预防措施 oxaliplatin dexamethasone pathogenesis high risk factors prevention measures
  • 相关文献

参考文献4

二级参考文献44

  • 1Brandi G, Pantaleo MA, Galli C, et al. Hypersensitivity reactions related to oxaliplatin (OHP) [J]. Br J Cancer, 2003, 89(3) :477-481.
  • 2Thomas RR, Quinn MG, Schuler B, et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin [J]. Cancer, 2003, 97(9) : 2301-2307.
  • 3Siu SW, Chan RT, Au GK. Hypersensitivity reactions to oxaliplatin: experience in a single institute [J]. Ann Oncol, 2006,17(2) :259-261.
  • 4Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes [J]. Lancet, 1977,1 ( 8009 ) : 466-469.
  • 5Polyzos A, Tsavaris N, Gogas H, et al. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience [J]. Oncology, 2009,76( 1 ) : 36-41.
  • 6Maindrault-Goebel F, Andre T, Tournigand C, et al. Allergictype reactions to oxaliplatin: retrospective analysis of 42 patients [J ]. Eur J Cancer, 2005,41 (15) : 2262-2267.
  • 7Lee MY, Yang MH, Liu JH, et al. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication [J]. Support Care Cancer, 2007, 15(1):89-93.
  • 8Larzilliere I, Brandissou S, Breton P. et al. Anaphylaetic reaction to oxaliplatin: a case report [J].Am J Gastroenterol, 1999,94( 11 ) :3387-3388.
  • 9Finkehnan FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models [J].J Allergy Clin hnmunol, 2005,115(3):449-457.
  • 10Strait R, Morrist SC, Finkelman FD. Cytokine enhancement of anaphylaxis [J]. No~artis Found Syrup, 2004. 257 : 80-91.

共引文献46

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部